Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates
Circulation · 31.10.2023 · 148 (18) · 1395-1409
DOI: 10.1161/circulationaha.122.061736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 31.10.2023. Verfasst von Yu-Che Cheng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taiwan (Y.C.C., C.J.L., C.Y.H., C.Y.T., D.Z.H.C., M.W.N., P.J.L., H.C.C., P.C.H.H.). Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocardial Infarction. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Remuscularization of the mammalian heart can be achieved after cell transplantation of human induced pluripotent stem cell (hiPSC)–derived cardiomyocytes (CMs). However, several hurdles remain before implementation into clinical practice. Poor survival of the implanted cells is related to insufficient vascularization, and the potential for fatal arrhythmogenesis is associated with the fetal cell–like nature of immature CMs. METHODS: We generated 3 lines of hiPSC-derived endothelial cells (ECs) and hiPSC-CMs from 3 independent donors and tested hiPSC–CM sarcomeric length, gap junction protein, and calcium-handling ability in coculture with ECs. Next, we examined the therapeutic effect of the cotransplantation of hiPSC-ECs and hiPSC-CMs in nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice undergoing myocardial infarction (n≥4). Cardiac function was assessed by echocardiography, whereas arrhythmic events were recorded using 3-lead ECGs. We further used healthy non-human primates (n=4) with cell injection to study the cell engraftment, maturation, and integration of transplanted hiPSC-CMs, alone or along with hiPSC-ECs, by histological analysis. Last, we tested the cell therapy in ischemic reperfusion injury in non-human primates (n=4, 3, and 4 for EC+CM, CM, and control, respectively). Cardiac function was evaluated by echocardiography and cardiac MRI, whereas arrhythmic events were monitored by telemetric ECG recorders. Cell engraftment, angiogenesis, and host–graft integration of human grafts were also investigated. RESULTS: We demonstrated that human iPSC-ECs promote the maturity and function of hiPSC-CMs in vitro and in vivo. When cocultured with ECs, CMs showed more mature phenotypes in cellular structure and function. In the mouse model, cotransplantation augmented the EC-accompanied vascularization in the grafts, promoted the maturity of CMs at the infarct area, and improved cardiac function after myocardial infarction. Furthermore, in non-human primates, transplantation of ECs and CMs significantly enhanced graft size and vasculature and improved cardiac function after ischemic reperfusion. CONCLUSIONS: These results demonstrate the synergistic effect of combining iPSC-derived ECs and CMs for therapy in the postmyocardial infarction heart, enabling a promising strategy toward clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Academia Sinica, Taiwan (Y.C.C., C.J.L., C.Y.H., C.Y.T., D.Z.H.C., M.W.N., P.J.L., H.C.C., P.C.H.H.).
- Model Organisms Research Core, Department of Medicine (M.L.H., C.M.C.C., T.A.H.), University of Wisconsin-Madison.
- Wisconsin National Primate Research Center (R.P., A.W.M., J.C., P.B., H.A.S.), University of Wisconsin-Madison.
- Department of Medicine and Stem Cell and Regenerative Medicine Center (G.C.K., J.Z., T.J.K., P.C.H.H.), University of Wisconsin-Madison.
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan (Y.W.L.).
- Institute of Medical Genomics and Proteomics and Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan (P.C.H.H.).
ORCID-Profile: Puja Basu, Heather A Simmons, Timothy J Kamp, Patrick C H Hsieh
Förderung
- NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Cheng, Y. C., Hsieh, M. L., Lin, C. J., Chang, C. M. C., Huang, C. Y., Puntney, R., Wu Moy, A., Ting, C. Y., Herr Chan, D. Z., Nicholson, M. W., Lin, P. J., Chen, H. C., Kim, G. C., Zhang, J., Coonen, J., Basu, P., Simmons, H. A., Liu, Y. W., Hacker, T. A., …, & Hsieh, P. C. H. (2023). Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates. Circulation, 148(18), 1395-1409. https://doi.org/10.1161/circulationaha.122.061736
Vancouver
Cheng YC, Hsieh ML, Lin CJ, Chang CMC, Huang CY, Puntney R, et al. Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates. Circulation. 2023;148(18):1395-1409. doi:10.1161/circulationaha.122.061736
BibTeX
@article{Cheng2023,
author = {Cheng, Yu-Che and Hsieh, Marvin L and Lin, Chen-Ju and Chang, Cindy M C and Huang, Ching-Ying and Puntney, Riley and Wu Moy, Amy and Ting, Chien-Yu and Herr Chan, Darien Zhing and Nicholson, Martin W and Lin, Po-Ju and Chen, Hung-Chih and Kim, Gina C and Zhang, Jianhua and Coonen, Jennifer and Basu, Puja and Simmons, Heather A and Liu, Yen-Wen and Hacker, Timothy A and Kamp, Timothy J and Hsieh, Patrick C H},
title = {Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates},
journal = {Circulation},
year = {2023},
volume = {148},
number = {18},
pages = {1395--1409},
doi = {10.1161/circulationaha.122.061736}
}
EUVIMED